[1]罗淼,李宁,裴环,等.生姜主要活性成分防治骨质疏松症的肠-骨轴作用机制研究进展[J].中医正骨,2025,37(08):42-45.
点击复制

生姜主要活性成分防治骨质疏松症的肠-骨轴作用机制研究进展()

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第37卷
期数:
2025年08期
页码:
42-45
栏目:
综述
出版日期:
2025-08-20

文章信息/Info

作者:
罗淼1李宁1裴环2王富能3马聪3邓力1吴瑞华1杨朋仪3李律宇1
1.昆明市中医医院,云南 昆明 650500; 2.天津中医药大学,天津 301617; 3.云南中医药大学,云南 昆明 650500
关键词:
生姜 有效成分 骨质疏松 肠-骨轴 脂肪酸类挥发性 胃肠道微生物群 综述
摘要:
骨质疏松症(osteoporosis,OP)是常见的代谢性骨病,其具体发病机制目前尚不完全清楚。肠-骨轴是肠道微生物群与骨骼系统之间双向调控的重要网络,其调控机制与生姜的药理作用高度吻合。本文介绍了生姜主要活性成分及其防治OP的相关研究,从肠-骨轴与OP的关系、生姜主要活性成分调控肠-骨轴的作用机制2个方面对相关研究进展进行了综述。

参考文献/References:

[1] WANG L,LI Y J,GU J L,et al.Knowledge,awareness and perception towards osteoporosis risk in China:a systematic review[J].Iran J Public Health,2024,53(5):1009-1020.
[2] 赵文生,李孝林,彭昌华,等.肠道菌群与骨质疏松性骨折[J].中国组织工程研究,2025,29(6):1296-1304.
[3] 罗湘杭,周若玙.骨质疏松的病因及发病机制研究进展[J].山东大学学报(医学版),2021,59(6):10-15.
[4] TU Y,YANG R,XU X,et al.The microbiota-gut-bone axis and bone health[J].J Leukoc Biol,2021,110(3):525-537.
[5] 张建,李嘉程,王辉,等.基于肠-骨轴理论探讨肠道菌群对股骨头坏死的作用机制[J].中医正骨,2025,37(4):77-80.
[6] SHARIFI-RAD M,VARONI E M,SALEHI B,et al.Plants of the genus zingiber as a source of bioactive phytochemicals:from tradition to pharmacy[J].Molecules,2017,22(12):2145.
[7] MAO Q Q,XU X Y,CAO S Y,et al.Bioactive compounds and bioactivities of ginger(zingiber officinale roscoe)[J].Foods,2019,8(6):185.
[8] BOSE S,WHITE B,CHAUDHARI V S.Gingerol encapsulated lipid nanoparticles on 3D-printed scaffolds for orthopedic and dental applications[J].Biomater Adv,2025,172:214194.
[9] DE VOS B,KASONGA A E,JOUBERT A M,et al.Exploring the in vitro effects of zingerone on differentiation and signalling pathways in bone cell lines[J].Metabolites,2024,14(12):693.
[10] LIANG Q H,DU H L,WANG Y J,et al.Integrated metabolomics and gut microbiota analysis to explore the protective effects of Gushudan on postmenopausal osteoporosis rats via gut-bone axis[J].J Pharm Biomed Anal,2025,263:116942.
[11] MUSKIET M H A,WINTER E M,RENSEN P C N,et al.The gut-bone axis:implications of gut hormone-based therapies for bone health[J].Lancet Diabetes Endocrinol,2025,13(5):364-367.
[12] ZHAO X L,XU L Y,LI K D,et al.Exploring dried ginger essential oil as a therapeutic strategy for 5-FU-induced mucositis:g ut microbiota and tryptophan metabolite IAA-AHR/IL-22/STAT3 signaling axis[J].J Ethnopharmacol,2025,345:119616.
[13] SHEN C L,SANTOS J M,ELMASSRY M M,et al.Crosstalk among gut microbiota,fecal metabolites,and amygdala neuropathology genes after ginger polyphenol administration in female rats with neuropathic pain:evidence for microbiota-gut-brain connection[J].Nutrients,2025,17(9):1444.
[14] SHAUKAT M N,NAZIR A,FALLICO B.Ginger bioactives:a comprehensive review of health benefits and potential food applications[J].Antioxidants(Basel),2023,12(11):2015.
[15] 罗祺玮,钟萍,孟钢,等.生姜与干姜挥发油化学成分及药理作用研究进展[J].生物化工,2024,10(3):184-188.
[16] ZHANG Q Y,GONG H B,JIANG M Y,et al.Regulation of enzymatic lipid peroxidation in osteoblasts protects against postmenopausal osteoporosis[J].Nat Commun,2025,16(1):758.
[17] SRINAATH N,BALAGANGADHARAN K,POOJA V,et al.Osteogenic potential of zingerone,a phenolic compound in mouse mesenchymal stem cells[J].Biofactors,2019,45(4):575-582.
[18] ZANG L,KAGOTANI K,NAKAYAMA H,et al.10-Gingerol suppresses osteoclastogenesis in RAW264.7 cells and zebrafish osteoporotic scales[J].Front Cell Dev Biol,2021,9:588093.
[19] SALEKZAMANI Y,SHAKOURI S K,DOLATKHAH N,et al.The effect of ginger and curcumin co-supplementation in postmenopausal women with osteoporosis:a randomised,triple-blind,placebo-controlled clinical trial[J].J Herb Med,2023,42:100746.
[20] USEFIAN F,FARSHBAF-KHALILI A,MIRGHAFOURVAND M,et al.Effect of curcumin and/or nigella sativa on bone density and quality of life in postmenopausal women with osteoporosis or osteopenia[J].Adv Integr Med,2024,11(1):17-23.
[21] 干佳玥,杨保同,赵大治.肠道菌群与老年骨质疏松患者骨密度、骨代谢的相关性[J].广东医学,2022,43(10):1259-1264.
[22] SHIEH A,EPELDEGUI M,KARLAMANGLA A S,et al.Gut permeability,inflammation,and bone density across the menopause transition[J].JCI Insight,2020,5(2):e134092.
[23] YANG F,YAN Q X,WANG Y H,et al.AMP1-1 alleviates bone loss in weightless rats by reducing peripheral 5-HT content via the microbiota-gut-bone axis[J].Phytomedicine,2025,139:156447.
[24] 李宁,吴月滢,裴环,等.基于“肠-骨”轴探讨药食同源复方强骨宁缓解绝经后骨质疏松症的作用机制[J].中华中医药杂志,2024,39(5):2308-2315.
[25] DAR H Y,PAL S,SHUKLA P,et al.Bacillus clausii inhi-bits bone loss by skewing Treg-Th17 cell equilibrium in postmenopausal osteoporotic mice model[J].Nutrition,2018,54:118-128.
[26] EPSLEY S,TADROS S,FARID A,et al.The effect of inflammation on bone[J].Front Physiol,2021,11:511799.
[27] SONG W,SHENG Q L,BAI Y Y,et al.Obesity,but not high-fat diet,is associated with bone loss that is reversed via CD4+ CD25+ Foxp3+ tregs-mediated gut microbiome of non-obese mice[J].NPJ Sci Food,2023,7(1):14.
[28] XIAO L P,ZHOU Y J,BOKOLIYA S,et al.Bone loss is ameliorated by fecal microbiota transplantation through SCFA/GPR41/IGF1 pathway in sickle cell disease mice[J].Sci Rep,2022,12(1):20638.
[29] LUCAS S,OMATA Y,HOFMANN J,et al.Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss[J].Nat Commun,2018,9(1):55.
[30] FENG B Y,LU J J,HAN Y H,et al.The role of short-chain fatty acids in the regulation of osteoporosis:new perspectives from gut microbiota to bone health:a review[J].Medicine(Baltimore),2024,103(34):e39471.
[31] KIM J,HA J,KIM S,et al.Impact of ginger on gut microbiota composition and function in a bacteroides-dominant enterotype[J].J Microbiol Biotechnol,2025,35:e2503032.
[32] HAO W,CHEN Z J,YUAN Q,et al.Ginger polysaccharides relieve ulcerative colitis via maintaining intestinal barrier integrity and gut microbiota modulation[J].Int J Biol Macromol,2022,219:730-739.
[33] ZHAN Z Y,TANG H,ZHANG Y,et al.Potential of gut-derived short-chain fatty acids to control enteric pathogens[J].Front Microbiol,2022,13:976406.
[34] LIANG J,DAI W G,LIU C H,et al.Gingerenone a attenuates ulcerative colitis via targeting IL-17RA to inhibit inflammation and restore intestinal barrier function[J].Adv Sci(Weinh),2024,11(28):e2400206.
[35] MAHLUJI S,OSTADRAHIMI A,MOBASSERI M,et al.Anti-inflammatory effects of zingiber officinale in type 2 diabe-tic patients[J].Adv Pharm Bull,2013,3(2):273-276.
[36] ZHANG Z C,CUI Y Q,LIU S Y,et al.Short-term treatment with zingerone ameliorates dextran sulfate sodium-induced mouse experimental colitis[J].J Sci Food Agric,2022,102(11):4873-4882.
[37] WANG J,CHEN Y,HU X S,et al.Assessing the effects of ginger extract on polyphenol profiles and the subsequent impact on the fecal microbiota by simulating digestion and fermentation in vitro[J].Nutrients,2020,12(10):3194.

相似文献/References:

[1]李向洲,邢涛,张应拴,等.中药治疗激素性股骨头坏死作用机制的研究进展[J].中医正骨,2023,35(02):33.
[2]赵钰,李纪高,周全.虎杖有效成分基于类风湿关节炎相关信号通路治疗类风湿关节炎作用机制的研究进展[J].中医正骨,2023,35(04):28.

备注/Memo

备注/Memo:
基金项目:云南省科技厅科技计划项目(202101AZ070001-093,202101AZ070001-242,202101AZ070001-294); 云南省临床医学中心科研项目(2024YNLCYXZX0294); 云南省中西医结合慢病防治重点实验室开放课题基金项目(YPKLG2024-001,YPKLG2024-020)
通讯作者:李律宇 E-mail:lilvyu@qq.com
更新日期/Last Update: 1900-01-01